Price Data


Syneron Medical Ltd. (NASDAQ: ELOS) is a leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint.

The Company’s technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring,  hair removal, wrinkle reduction, improving the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela.  

Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US.  The company markets, services and supports its products in 86 countries.  It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.

Additional information can be found at


Syneron Investor Presentation February 2015
Syneron Investor Presentation February 2015 (2.7 MB)

Syneron Events
Thursday, March 12, 2015
8:00am EDT

Hugo Goldman, Chief Financial Officer, is scheduled to participate in the Barclays Global Healthcare Conference in Miami, FL. Mr. Goldman will participate in a fireside chat presentation at the...

Wednesday, February 18, 2015
8:30am EST

Syneron management will host a conference call and a live webcast. A question & answer session will follow management's discussion of events in the fourth quarter 2014. Investors and analysts may...

See calendar

print email